Virtu Financial LLC Arbutus Biopharma Corp Transaction History

Virtu Financial LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$1.69 - $2.54 $30,289 - $45,524	17,923 New	17,923 $45,000
Q1 2023 May 01, 2023	SELL	$2.23 - $3.1 $71,328 - $99,156	-31,986 Reduced 72.38%	12,208 $37,000
Q4 2022 Feb 15, 2023	BUY	$1.91 - $2.85 $84,410 - $125,952	44,194 New	44,194 $103,000
Q2 2022 Aug 09, 2022	BUY	$1.98 - $3.17 $104,389 - $167,128	52,722 New	52,722 $143,000
Q3 2021 Nov 12, 2021	SELL	$2.65 - $4.62 $246,969 - $430,565	-93,196 Closed	0 $0

Q2 2021 Sep 17, 2021	BUY	$2.5 - $3.51 $73,137 - $102,685	29,255 Added 45.75%	93,196 $282,000
Q1 2021 May 19, 2021	BUY	$3.14 - $4.84 $4,430 - $6,829	1,411 Added 2.26%	63,941 $213,000
Q4 2020 Feb 24, 2021	BUY	$2.76 - $4.97 $172,582 - $310,774	62,530 New	62,530 $222,000
Q3 2020 Dec 11, 2020	SELL	$1.75 - $6.2 $30,007 - $106,311	-17,147 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$0.91 - $2.36 $15,603 - $40,466	17,147 New	17,147 $31,000
Q3 2019 Nov 20, 2019	SELL	$1.34 - $2.4 $32,894 - $58,915	-24,548 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$1.46 - $4.44 $35,840 - $108,993	24,548 New	24,548 $51,000
Q1 2018 May 14, 2018	SELL	$4.4 - $6.05 $49,662 - $68,286	-11,287 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$4.45 - $7.7 $50,227 - $86,909	11,287	11,287 $57,000

130

82.2M

4.82M

546K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $489M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.